Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006

Acta Oncologica

Volumn 49, Issue 5, 2010, Pages 673-693

  Bray, Freddie ^a,b   Engholm, Gerda ^c   Hakulinen, Timo ^d   Gislum, Mette ^c   Tryggvadóttir, Laufey ^e,f   Storm, Hans H ^c   Klint, Åsa ^g  

^a Cancer Registry of Norway ^*  (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d FINNISH CANCER REGISTRY   (Finland)

^e ICELANDIC CANCER REGISTRY   (Iceland)

^f UNIVERSITY OF ICELAND   (Iceland)

^g NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BONE CANCER; BRAIN CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; DENMARK; EYE CANCER; FINLAND; FOLLOW UP; HUMAN; ICELAND; NERVOUS SYSTEM TUMOR; NORWAY; OSTEOSARCOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SOFT TISSUE CANCER; SOFT TISSUE SARCOMA; SWEDEN; THYROID CANCER; TREND STUDY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; DENMARK; EYE NEOPLASMS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; ICELAND; INCIDENCE; LYMPHATIC METASTASIS; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; NEOPLASM STAGING; NERVOUS SYSTEM NEOPLASMS; NORWAY; REGISTRIES; RISK FACTORS; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; THYROID NEOPLASMS;

EID: 77952826167     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003610200     Document Type: Article

References (39)

1. Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Ólafsdóttir E, et al. NORDCAN: Cancer incidence, mortality and prevalence in the Nordic countries, Version 3.3. http://www. ancr.nu 2008.
2. Muir CS, Storm HH, Polednak A. Brain and other nervous system tumours. Cancer Surv 1994;19-20:369-92.
3. Magnani C, Aareleid T, Viscomi S, Pastore G, Berrino F. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: The EUROCARE study. Eur J Cancer 2001;37: 711-21.
4. Sant M, van der Sanden G, Capocaccia R. Survival rates for primary malignant brain tumours in Europe. Eur J Cancer 1998 1;34:2241-7.
5. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
6. Hall P, Adami HO. Thyroid cancer. In: Adami HO, Hunter D, Trichopolous D, editors. Textbook of cancer epidemiology 2nd ed. Oxford: Oxford University Press; 2008. pp. 188-211.
7. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009; 20:525-31.
8. Soderstrom N. Puncture of goiters for aspiration biopsy. Acta Med Scand 1952;144:237-44.
9. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents Vol. IX (IARC Scientific Publication No 160). Lyon: IARC; 2007.
10. Isager P, Engholm G, Overgaard J, Storm H. Uveal and conjunctival malignant melanoma in Denmark 1943-97: Observed and relative survival of patients followed through 2002. Ophthalmic Epidemiol 2006;13:85-96.
11. MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42: 2092-102. (Pubitemid 44224062)
12. Miller RM, Boice JD, Curtis RE. Bone cancer. In: Cancer epidemiology and prevention 3rd ed. New York: Oxford University Press; 2006.
13. Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42:2124-35.
14. Storm HH. Survival of adult patients with cancer of soft tissues or bone in Europe. Eur J Cancer 1998;34:2212-7.
15. Pastore G, Peris-Bonet R, Carli M, Martinez-Garcia C, Sanchez dT, Steliarova-Foucher E. Childhood soft tissue sarcomas incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42: 2136-49.
16. Stiller CA, Stevens MC, Magnani C, Corazziari I. Survival of children with soft-tissue sarcoma in Europe since 1978: Results from the EUROCARE study. Eur J Cancer 2001; 37:767-74. (Pubitemid 32304413)
17. Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods. Acta Oncol; 2010.
18. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307-16.
19. Savitz DA, Trichopolous D. Brain cancer. In: Adami HO, Hunter D, Trichopolous D, editors. Textbook of cancer epidemiology 2nd ed. Oxford: Oxford University Press; 2008. pp. 188-211.
20. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27-33.
21. Curran WJ, Jr., Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85: 704-10.
22. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998;88:1-10.
23. Shugg D, Allen BJ, Blizzard L, Dwyer T, Roder D. Brain cancer incidence, mortality and case survival: Observations from two Australian cancer registries. Int J Cancer 1994;59: 765-70.
24. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol 2003;30(6 Suppl 19):10-4.
25. Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, et al. The advantage of women in cancer survival: An analysis of EUROCARE-4 data. Eur J Cancer 2009;45:1017-27.
26. Johannesen TB, Langmark F, Lote K. Cause of death and longterm survival in patients with neuro-epithelial brain tumours: A population-based study. Eur J Cancer 2003;39:2355-63.
27. Teppo L, Hakulinen T. Variation in survival of adult patients with thyroid cancer in Europe. EUROCARE Working Group. Eur J Cancer 1998;34(14 Spec No):2248-52.
28. Colonna M, Grande E, Jonasson JG, Eurocare Working Group. Variation in relative survival of thyroid cancers in Europe: Results from the analysis on 21 countries over the period 1983-1994 (EUROCARE-3 study). Eur J Cancer 2006;42:2598-608.
29. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 2006;106:524-31.
30. Hakulinen T. A comparison of nationwide cancer survival statistics in Finland and Norway. World Health Stat Q 1983;36:35-46.
31. Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, et al. EUROCARE-3: Survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003;14(Suppl 5):v61-118.
32. Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, Dickman PW. Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer 2003;106: 569-73.
33. Forey B, Hamling J, Lee P, Wald N. International smoking statistics. A collection of historical data from 30 economically developed countries, 2nd ed. Vol.London & Oxford: Wolfson Institute of Preventive Medicine and Oxford University Press; 2002.
34. Bergman L, Nilsson B, Ragnarsson-Olding B, Seregard S. Uveal melanoma: A study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci 2006;47:72-7.
35. Hakulinen T. Sarkoomien epidemiologia (in Finnish). Focus Oncologiae 2006;7:8-13.
36. Smeland S, Muller C, Alvegard TA, Wiklund T, Wiebe T, Bjork O, et al. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: Prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003;39:488-94.
37. Swallow CJ, Catton CN. Local management of adult soft tissue sarcomas. Semin Oncol 2007;34:256-69.
38. Pastore G, Peris-Bonet R, Carli M, Martinez-Garcia C, Sanchez de Toledo J, Steliarova-Foucher E. Childhood soft tissue sarcomas incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2136-49.
39. Berwick M. Soft tissue sarcoma. In: Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006.